Amarin Corp Plc (AMRN)

[ggwpq]

"ready to add more drugs to the cardio group, with no caps on cost so long as they can enter into a race for either first- or best-in-class status in a key field."

“We look at lots of different assets,” Li responded, and follow up on those drugs that can have a major impact on patients’ lives. “I don’t know we’re constrained or contained by a certain size; it’s unmet need.”

With that kind of open checkbook strategy, it’s clear that Merck plans to remain at the bargaining table for some time to come.

https://endpts.com/fresh-off-an-11-5b-cardio-wager-merck-promises-investors-a-megablockbuster-future-in-a-return-to-the-glory-days/